Global hemostats market is highly fragmented and the major players
have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of hemostats
market for Global, Europe, North America, Asia-Pacific, South America and
Middle East & Africa.
Global Hemostats Market is expected to rise from its initial
estimated value of USD 3.06 billion in 2018 to an estimated value of USD 5.02
billion by 2026, registering a CAGR of 6.4% in the forecast period of 2019-2026.
This rise in market value can be attributed to the rising number of surgical
procedures.
Download
PDF Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
Key Market Competitors:
Global Hemostats Market
·
Ethicon US LLC (US),
·
Baxter (US),
·
Teleflex Incorporated (US),
·
B. Braun Melsungen AG (Germany),
·
3-D Matrix Medical Technology (Japan),
·
RESORBA Medical GmbH,
·
Anika Therapeutics, Inc. (US),
·
Arch Therapeutics, Inc. (US),
·
Biom’up SAS,
·
CryoLife, Inc. (US),
·
Gamma Therapeutics, Inc. (US),
·
Hemostasis, LLC. (USA),
·
MedTrade Products Limited (UK),
·
Integra LifeSciences (US),
·
Medline Industries, Inc (US),
·
HEMOTEC MEDICAL GMBH (Germany),
·
Stryker (US),
·
CSL (US),
·
Mallinckrodt company (UK),
·
Equimedica (Europe),
·
Others.
Key Developments in the Market:
·
In April 2019, Biom’up announced that the U.S. Food and Drug
Administration (FDA) approved the IDE (Investigational Device Exemption)
application for HEMOSNOW, a hemostatic dry powder made from porcine collagen
and bovine-derived chondroitin sulfate developed by the Company for managing
minimal and mild levels of bleeding during surgical procedures.
·
In January 2019, Biom’up Company, specializing in surgical
hemostasis announced that the U.S. Food and Drug Administration (FDA) has
granted marketing approval for its HEMOBLAST Bellows Laparoscopic Applicator
for all minimally-invasive procedures.
Market Definition: Global
Hemostats Market
The hemostat can be defined as a surgical tool which is used to
control blood loss or halt bleeding during major surgical. Basically it is used
in early phases of surgery for an initial incision that closes blood vessels
until ligation. It contain group of instruments which include needle holders,
pivot, various clamps and various clamps.
According to the American Joint Replacement Surgery 2016, around
427,181 total surgical procedures were reported for joint replacement surgery
in the U.S. However, the cluttering of surgical field due to multiple clamp
attachment causing inconvenience to the surgeons and thus, leading to surgical
errors is expected to hinder the market growth.
Market Drivers
·
Increasing healthcare expenditure and infrastructure, this
significant act as driver to the market.
·
Increasing number of technological advancement, this significant
act as driver to the market.
Market Restraints
·
Highly consolidated market, this act as restraints to the market.
Order a Copy of Global Hemostats Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market
Segmentation: Global
Hemostats Market
By Product Type
·
Thrombin Based
·
Combination
·
Oxidized Regenerated Cellulose Based
·
Gelatin Based
·
Collagen Based Hemostat
By Indication
·
Wound Closure
·
Surger
By Formulation
·
Matrix & Gel Hemostats
·
Sheet & Pad Hemostats
·
Sponge Hemostats
·
Powder Hemostats
By Application
·
Orthopedic Surgery
·
General Surgery
·
Neurological Surgery
·
Cardiovascular Surgery
·
Reconstructive Surgery
·
Gynecological Surgery
By End User
·
Hospitals
·
Clinics
·
Ambulatory Centers
·
Community Healthcare
·
Others
By Geography
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Middle East & Africa
Reasons to Purchase this Report
·
Current and future of global hemostats market outlook in the
developed and emerging markets
·
The segment that is expected to dominate the market as well as the
segment which holds highest CAGR in the forecast period
·
Regions/Countries that are expected to witness the fastest growth
rates during the forecast period
·
The latest developments, market shares, and strategies that are
employed by the major market players
Customization of the Report:
·
All segmentation provided above in this report is represented at
country level
·
All products covered in the market, product volume and average
selling prices will be included as customizable options which may incur no or
minimal additional cost (depends on customization)
Table of Contents:
1. INTRODUCTION
1.1. OBJECTIVES OF THE
STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL
HEMOSTATS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR
THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS
WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4. PREMIUM INSIGHTS
5. REGULATORY
5.1. OVERVIEW
5.2. REGULATORY PROCEDURE
6. REIMBURSEMENT
6.1. OVERVIEW
6.2. REIMBURSEMENT SCENARIO
7. EXECUTIVE SUMMARY
8. GLOBAL HEMOSTATS MARKET,
BY TYPE
9. GLOBAL HEMOSTATS
MARKET,BY APPLICATION
10. GLOBAL HEMOSTATS
MARKET, BY DISTRIBUTION CHANNEL
11. GLOBAL HEMOSTATS
MARKET, BY END USER
12. GLOBAL HEMOSTATS
MARKET, BY GEOGRAPHY
13. GLOBAL HEMOSTATS
MARKET, COMPANY LANDSCAPE
13.1. COMPANY SHARE
ANALYSIS: GLOBAL
13.2. COMPANY SHARE
ANALYSIS: NORTH AMERICA
13.3. COMPANY SHARE
ANALYSIS: EUROPE
13.4. COMPANY SHARE
ANALYSIS: APAC
14. COMPANY PROFILES
14.1. ETHICON US, LLC
(SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)
14.2. PFIZER
14.3. C.R BARD
14.4. BAXTER
14.5. VASCULAR SOLUTIONS,
INC (ACQUIRED BY TELEFLEX INCORPORATED)
14.6. B.BRAUN MELSUNGEN AG
14.7. 3-D MATRIX LTD
14.8. RESORBA MEDICAL GMBH
14.9. ANIKA THERAPEUTICS,
INC.
14.10. BIOM’UP
14.11. CRYOLIFE, INC.
14.12. EQUIMEDICAL
14.13. HEMOSTASIS, LLC
14.14. MEDTRADE PRODUCTS
LIMITED
14.15. STRYKER
14.16. ARCH THERAPEUTICS,
INC.
14.17. INTEGRA LIFESCIENCES
CORPORATION
14.18. ALTAYLAR MEDICAL
14.19. BIOCER
ENTWICKLUNGS-GMBH
14.20. SMI (STARCH MEDICAL)
About Data Bridge Market Research
An absolute way to forecast
what future holds is to comprehend the trend today!
Data Bridge set forth itself
as an unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business challenges and initiates an
effortless decision-making process. Data Bridge is an aftermath of sheer wisdom
and experience which was formulated and framed in the year 2015 in Pune.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475